MWOBX
Price
$50.62
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
RPEBX
Price
$59.87
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

MWOBX vs RPEBX

Header iconMWOBX vs RPEBX Comparison
Open Charts MWOBX vs RPEBXBanner chart's image
MFS Global Growth B
Price$50.62
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R2E
Price$59.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MWOBX vs RPEBX Comparison Chart
Loading...
VS
MWOBX vs. RPEBX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MWOBX is a StrongBuy and RPEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 142B vs. MWOBX (985M). RPEBX pays higher dividends than MWOBX: RPEBX (0.46) vs MWOBX (0.00). MWOBX was incepted earlier than RPEBX: MWOBX (31 years) vs RPEBX (10 years). MWOBX is a more actively managed with annual turnover of: 24.00 vs. RPEBX (17.00). RPEBX has a lower initial minimum investment than MWOBX: RPEBX (250) vs MWOBX (1000). RPEBX annual gain was more profitable for investors over the last year : 16.17 vs. MWOBX (14.02). RPEBX return over 5 years is better than : 40.91 vs. MWOBX (31.24).
MWOBXRPEBXMWOBX / RPEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years10 years-
Gain YTD10.87014.31276%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets985M142B1%
Annual Yield % from dividends0.000.46-
Returns for 1 year14.0216.1787%
Returns for 3 years-4.64-8.0658%
Returns for 5 years31.2440.9176%
Returns for 10 years65.3162.23105%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX16.411.33
+8.82%
Inhibrx Biosciences Inc.
STM28.590.64
+2.29%
STMicroelectronics NV
HLF7.420.13
+1.78%
Herbalife Ltd
TRIP13.510.18
+1.35%
TripAdvisor
CGTX0.60N/A
-0.58%
Cognition Therapeutics